Factors affecting solubilization of a poorly soluble novel tubulin-binding agent

By Shah Amit K.   Wyandt Christy M.  

Pharmaceutical Development and Technology, Vol. 18, Iss. 6, 2013-12 ,pp. : 1319-1328

Informa Healthcare

Access to resources Recommend Favorite

The diaryl oxazole PC-046 is a tubulin-binding agent with experimental anti-tumor efficacy in hematologic cancers

By Landowski Terry   Samulitis Betty   Dorr Robert  

Investigational New Drugs, Vol. 31, Iss. 6, 2013-12 ,pp. : 1616-1625

Springer Publishing Company

Access to resources Recommend Favorite

Implications of Nanoscale Based Drug Delivery Systems in Delivery and Targeting Tubulin Binding Agent, Noscapine in Cancer Cells

By  

Current Drug Metabolism, Vol. 13, Iss. 10, 2012-12 ,pp. : 1476-1483

Bentham Science Publishers

Access to resources Recommend Favorite

A new perspective on old drugs: non-mitotic actions of tubulin-binding drugs play a major role in cancer treatment

By Fürst R.   Vollmar A. M.  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 68, Iss. 7, 2013-07 ,pp. : 478-483

Govi-Verlag

Access to resources Recommend Favorite

Matrine: Bioactivities and Structural Modifications

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 28, 2016-09 ,pp. : 3365-3378

Bentham Science Publishers

Access to resources Recommend Favorite